Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "the Company") (stock abbreviation: *ST Zixin, stock code: 002118) experienced a cumulative deviation of 13.54% in closing prices on June 8, June 9, and June 12, 2023, which constitutes an abnormal fluctuation in stock trading according to the relevant provisions of the Shenzhen Stock Exchange trading rules.
002118SZSE
Announcement on Abnormal Fluctuations in Stock Trading
✨ AI Summary
This announcement addresses the abnormal fluctuations in the stock price of Jilin Zixin Pharmaceutical Co., Ltd. The stock price deviated by 13.54% over specific dates in June 2023. The company confirmed no undisclosed significant information affecting the stock price and reiterated its commitment to transparent information disclosure. Investors are advised to be cautious regarding investment risks.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.